A patient with an underlying anxiety disorder is experiencing an increase in psychogenic seizures, now occurring up to three times daily, with associated confusion and emotional lability. The multidisciplinary team has decided to increase the patient's sertraline dose and incorporate more regular cognitive-behavioral therapy (CBT). What is the primary nursing priority when implementing this revised care plan?

C) Evaluate the patient's ability to identify and manage specific stressors contributing to her seizure frequency.

A) Monitor for potential side effects of increased sertraline dosage, such as insomnia or gastrointestinal disturbances.

B) Educate the patient about the importance of adhering to the new medication regimen and attending CBT sessions.

C) Evaluate the patient's ability to identify and manage specific stressors contributing to her seizure frequency.

D) Coordinate with the occupational therapist to develop strategies for managing work-related stressors.

A patient with a history of psychogenic seizures and anxiety disorder is experiencing increased seizure frequency and emotional distress. The nursing team is considering interventions to address psychosocial stressors. Which of the following nursing actions is most appropriate to support the revised care plan?

A) Encourage the patient to journal daily about her thoughts and feelings.

B) Educate the patient on the side effects of increasing sertraline dosage.

C) Schedule regular relaxation therapy sessions focusing solely on breathing exercises.

D) Advise the patient to avoid all stressful situations immediately.

A patient with a history of psychogenic seizures and anxiety is experiencing significant side effects from an increased sertraline dosage, including insomnia and gastrointestinal discomfort. The multidisciplinary team is considering introducing a low-dose benzodiazepine for short-term relief of acute anxiety episodes. What is the nurse's priority intervention to ensure safe administration of benzodiazepines in this patient?

A) Monitor the patient for signs of respiratory depression, especially if combined with other CNS depressants.

B) Educate the patient about the potential for addiction with long-term use of benzodiazepines.

C) Advise the patient to take the medication with food to minimize gastrointestinal discomfort.

D) Ensure the patient understands the need to avoid driving or operating heavy machinery while on the medication.

A patient with a history of psychogenic seizures and anxiety is experiencing significant side effects from an increased dose of sertraline, including insomnia and gastrointestinal discomfort. Given her ongoing anxiety and the multidisciplinary team's consideration of introducing a low-dose benzodiazepine for acute anxiety episodes, what should the nurse prioritize in educating the patient about the use of benzodiazepines in conjunction with her current treatment plan?

B) Discuss the potential for dependence and the importance of using benzodiazepines only as prescribed for acute anxiety episodes.

A) Emphasize the importance of taking benzodiazepines regularly to prevent anxiety from building up.

B) Discuss the potential for dependence and the importance of using benzodiazepines only as prescribed for acute anxiety episodes.

C) Suggest discontinuing sertraline to minimize side effects and rely solely on benzodiazepines for anxiety management.

D) Encourage the patient to monitor her heart rate regularly as benzodiazepines can exacerbate autonomic arousal.

A patient with a history of psychogenic seizures and anxiety is experiencing insomnia and gastrointestinal discomfort from sertraline. The healthcare team is considering transitioning to an SNRI. As a nurse, what is the most appropriate intervention to address the patient's insomnia while awaiting medication adjustment?

A) Encourage the patient to take warm baths before bedtime to promote relaxation.

B) Advise the patient to increase caffeine intake during the day to combat fatigue.

C) Suggest the patient takes over-the-counter sleep aids nightly for immediate relief.

D) Recommend the patient engages in physical exercise immediately before bed.

A patient with anxiety and psychogenic seizures is experiencing significant side effects from sertraline, including insomnia and gastrointestinal discomfort, affecting her participation in therapy. Which nursing intervention is most appropriate to address her current needs while considering her long-term treatment goals?

C) Advocate for a transition to an SNRI and reinforce the use of cognitive-behavioral strategies.

A) Encourage the patient to increase her sertraline dosage to combat insomnia.

B) Suggest the addition of a sleep aid medication to manage her insomnia.

C) Advocate for a transition to an SNRI and reinforce the use of cognitive-behavioral strategies.

D) Recommend discontinuing all medications and focusing solely on non-pharmacological interventions.

A patient experiencing dizziness and blurred vision is found to have bradycardia and a prolonged QT interval after starting a new medication regimen. Which nursing intervention is most appropriate to prioritize for this patient?

B) Monitor the patient's heart rate and rhythm closely

A) Educate the patient about dietary modifications to manage dizziness

B) Monitor the patient's heart rate and rhythm closely

C) Encourage the patient to increase fluid intake to prevent dehydration

D) Schedule the patient for regular vision assessments

A patient with a history of autonomic dysregulation and recent medication changes presents with dizziness, blurred vision, and bradycardia. An ECG reveals a prolonged QT interval. Which nursing intervention should be prioritized to address the patient's current symptoms and prevent further complications?

B) Monitor the patient's heart rate and rhythm closely and report significant changes immediately.

A) Educate the patient on lifestyle modifications to manage hypertension.

B) Monitor the patient's heart rate and rhythm closely and report significant changes immediately.

C) Encourage the patient to increase fluid intake to prevent dehydration.

D) Schedule the patient for regular vision checks to assess for potential ocular damage.

A patient who recently transitioned from sertraline to an SNRI reports mild tremors and increased anxiety in the afternoons. What is the most appropriate initial nursing intervention to address these symptoms?

B) Educate the patient on engaging in regular exercise and mindfulness practices to manage anxiety and reduce tremors.

A) Increase the frequency of blood pressure and heart rate monitoring to assess for cardiovascular side effects.

B) Educate the patient on engaging in regular exercise and mindfulness practices to manage anxiety and reduce tremors.

C) Recommend discontinuing the SNRI immediately and reverting to the previous medication.

D) Advise the patient to take an additional dose of SNRI in the afternoon to manage symptoms.

A patient transitioning from sertraline to an SNRI reports new symptoms of mild hand tremors and increased anxiety in the afternoons. Given these symptoms and the current management plan, what should be the nurse's priority action?

D) Monitor the patient's response to increased cognitive-behavioral therapy sessions and a potential SNRI dose adjustment.

A) Suggest the healthcare provider discontinue the SNRI immediately.

B) Encourage the patient to engage in regular exercise and mindfulness practices.

C) Prepare to administer a benzodiazepine as needed for acute anxiety.

D) Monitor the patient's response to increased cognitive-behavioral therapy sessions and a potential SNRI dose adjustment.

Psychogenic seizures - Nursing Case Study

Pathophysiology

• Primary mechanism: Psychogenic seizures, also known as nonepileptic seizures, primarily arise from psychological stressors or trauma. These stressors lead to altered emotional processing in the brain, particularly affecting the limbic system, which governs emotions and memory.

• Secondary mechanism: Dysfunction in the brain's communication pathways, especially involving the prefrontal cortex and amygdala, results in the physical manifestations of these seizures. This dysfunction can cause the brain to misinterpret emotional distress as a physical threat, triggering seizure-like episodes.

• Key complication: Misdiagnosis is common, as symptoms mimic epileptic seizures, leading to inappropriate treatments. Proper identification and management focus on addressing underlying psychological issues rather than neurological interventions.

Patient Profile

Demographics:

Age: 30, Gender: Female, Occupation: High school teacher

History:

• Key past medical history: History of anxiety disorder, previous episodes of unexplained fainting spells

• Current medications: Sertraline 50 mg daily, Lorazepam 0.5 mg as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Episodes of convulsions and loss of consciousness without a clear neurological cause

• Key symptoms: Involuntary movements, confusion post-episode, emotional distress, headache

• Vital signs: Blood pressure 140/90 mmHg, Heart rate 105 beats per minute, Respiratory rate 20 breaths per minute, Temperature 98.6°F

Section 1

Change in Patient Status:

Following initial assessment in the emergency department, the patient's condition evolves over the course of her hospital stay. She experiences increased frequency of her psychogenic seizures, now occurring up to three times daily. These episodes are accompanied by prolonged confusion and emotional lability, which is distressing for both the patient and her family. Her vital signs remain relatively stable, though her heart rate intermittently spikes to 120 beats per minute during episodes. This escalation in symptoms raises concerns about the impact of stressors in her daily life and the effectiveness of her current treatment regimen, particularly in managing her underlying anxiety disorder.

In light of her changing status, a multidisciplinary team meeting is convened to revise her care plan. The team, consisting of a neurologist, psychiatrist, and a psychiatric nurse, identifies the need for a more comprehensive psychological evaluation. They suspect that unresolved stressors related to her occupation as a high school teacher, possibly exacerbated by recent remote teaching challenges, may be contributing to her heightened emotional distress and seizure frequency. Additionally, the team considers adjusting her medication regime, proposing to increase her sertraline dosage to 75 mg daily, combined with more regular cognitive-behavioral therapy sessions to enhance coping strategies.

This shift in treatment focus underscores the importance of addressing the psychosocial factors impacting her health. The plan is to closely monitor her response to these interventions over the next few weeks, with an emphasis on identifying specific triggers for her seizures and developing personalized strategies to mitigate these stressors. This approach not only aims to reduce the frequency of her episodes but also to improve her quality of life by empowering her with tools to manage her anxiety more effectively.

Section 2

Over the following two weeks, the patient demonstrates a mixed response to the revised treatment plan. Her frequency of psychogenic seizures begins to decrease slightly, averaging one to two episodes per day. However, new complications arise as she starts to experience significant side effects from the increased sertraline dosage, including insomnia and gastrointestinal discomfort. These adverse effects contribute to her overall fatigue, further complicating her emotional lability and impacting her ability to engage fully in therapy sessions. Her vital signs remain stable outside of seizure episodes, but her heart rate continues to intermittently spike during these events, suggesting persistent autonomic arousal linked to her anxiety.

In addition to the medication side effects, the patient reveals during therapy sessions that she has been feeling overwhelmed by the dual responsibilities of teaching and adapting to new educational technologies. Despite her efforts to apply cognitive-behavioral strategies, she struggles to identify specific triggers for her seizures, as they appear to be sporadically linked to both professional and personal stressors. A follow-up psychological evaluation highlights a significant level of unresolved anxiety related to her role as an educator and a lack of adequate support systems at work.

These findings prompt the multidisciplinary team to consider further adjustments to her care plan, focusing on balancing the need to manage her anxiety with minimizing medication side effects. They deliberate on introducing a low-dose benzodiazepine for short-term relief of acute anxiety episodes, while also advocating for workplace accommodations to alleviate her stress. The team emphasizes the importance of continued support through therapy and encourages the patient to engage in stress-reduction practices, such as mindfulness and relaxation techniques. The goal remains to create a sustainable approach that empowers the patient to regain control over her health and well-being, while reducing the frequency and impact of her psychogenic seizures.

Section 3

Response to Interventions

Over the subsequent month, the patient experiences a nuanced response to the adjusted treatment plan. The introduction of a low-dose benzodiazepine provides her with temporary relief during acute anxiety episodes, which correlates with a further decrease in the frequency of her psychogenic seizures, now averaging one episode every two to three days. However, the team remains cautious about long-term benzodiazepine use due to potential dependency, emphasizing its role as a short-term measure. Concurrently, the patient exhibits improved adherence to her cognitive-behavioral strategies during therapy sessions, which helps her manage stress more effectively. Workplace accommodations, including a temporary reduction in her teaching load and access to technology training, contribute to a noticeable reduction in her reported stress levels.

Despite these positive developments, the patient continues to experience significant insomnia and gastrointestinal discomfort attributed to the sertraline, which persistently affects her overall energy levels and mood stability. A recent evaluation reveals that her sleep disturbances have exacerbated her fatigue, complicating her ability to participate fully in therapeutic activities. Vital sign monitoring shows that while her heart rate stability has improved outside of seizure episodes, she still experiences episodes of tachycardia during moments of heightened stress or anxiety, indicating ongoing autonomic dysregulation.

This complex interplay of improvements and challenges leads the multidisciplinary team to consider further modifications to her pharmacotherapy. They contemplate transitioning her from sertraline to a different class of antidepressant with a potentially more favorable side effect profile, such as a selective norepinephrine reuptake inhibitor (SNRI). The team continues to emphasize the importance of non-pharmacological interventions, encouraging her to deepen her practice of mindfulness and relaxation techniques. The patient expresses a renewed sense of hope as she acknowledges the progress made, yet remains aware of the journey ahead in managing her condition sustainably.

Section 4

In the weeks following the modification of her treatment plan, the patient begins to encounter new complications that challenge her progress. Despite the initial positive response to the adjusted interventions, she starts experiencing increased episodes of dizziness and occasional blurred vision. These symptoms prompt the healthcare team to conduct a comprehensive assessment to rule out any underlying physiological issues that may be contributing to her altered sensory experiences. During a routine follow-up appointment, her vital signs demonstrate consistent blood pressure readings but reveal intermittent episodes of bradycardia, with her heart rate occasionally dropping to 50 beats per minute during periods of rest. This finding raises concerns about potential cardiovascular side effects associated with her current medication regimen.

Laboratory tests, including a complete blood count, electrolyte panel, and thyroid function tests, return within normal limits, suggesting that her symptoms are not likely due to metabolic or endocrine disturbances. However, an electrocardiogram (ECG) conducted during one of her dizzy spells shows a prolonged QT interval, indicating a possible drug-induced cardiac effect. The team hypothesizes that the interactions between the low-dose benzodiazepine and sertraline, along with her existing autonomic dysregulation, could be contributing to these cardiac irregularities.

In response to these findings, the multidisciplinary team decides to taper her off the benzodiazepine, prioritizing the discontinuation of any medications that could exacerbate cardiovascular complications. Additionally, they initiate a gradual transition from sertraline to an SNRI, monitoring her closely for any adverse effects or improvement in her symptoms. The patient is counseled on the importance of reporting any new or worsening symptoms, particularly those related to her cardiovascular health. As she navigates these changes, the team remains committed to optimizing her treatment plan, balancing pharmacological adjustments with the reinforcement of non-pharmacological strategies to enhance her overall well-being and resilience. This careful reevaluation and adjustment aim to stabilize her condition while minimizing potential risks, setting the stage for the next phase of her therapeutic journey.

Section 5

As the patient progresses through the medication adjustments, the healthcare team remains vigilant in monitoring her response to the interventions. Approximately two weeks into the transition from sertraline to an SNRI, the patient reports a noticeable reduction in episodes of dizziness, suggesting a positive initial response to the medication switch. However, during a follow-up appointment, she mentions experiencing new symptoms of mild tremors in her hands and increased anxiety, particularly in the afternoons. Vital signs reveal a heart rate consistently in the mid-60s, with no further episodes of bradycardia, and blood pressure remains stable at 118/76 mmHg.

The clinical team conducts a thorough neurological assessment to explore the cause of the tremors. Neurological examination shows no signs of muscle weakness or coordination issues, and reflexes are normal, suggesting that the tremors may be a side effect of the new SNRI. Additionally, the patient's anxiety levels are assessed using the Generalized Anxiety Disorder 7-item (GAD-7) scale, which indicates moderate anxiety. This prompts the team to consider whether the SNRI dosage needs further adjustment or if additional non-pharmacological interventions should be intensified to manage her anxiety and tremors effectively.

To address these emerging symptoms, the team decides to implement cognitive-behavioral therapy (CBT) sessions more frequently, focusing on techniques to manage anxiety and stress, which may also help reduce the occurrence of tremors. Additionally, they consider a small dose adjustment of the SNRI, with careful monitoring for any changes in her condition. Education is provided to the patient about lifestyle modifications, such as regular exercise and mindfulness practices, to support her mental health. These holistic approaches aim to provide a more comprehensive management plan, ensuring that her treatment remains patient-centered and adaptive to her evolving needs. As the team continues to evaluate her progress, they remain prepared to make further adjustments to optimize her therapeutic outcomes.